跳至主要内容
临床试验/NCT05808257
NCT05808257已完成不适用

Superpulsed Thulium Fiber Laser VS. Pulse Modulated High Power Holmium:YAG Laser For Retrograde Intrarenal Surgery

Icahn School of Medicine at Mount Sinai2 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2022年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
82
试验地点
2
主要终点
Number of Participants With Stone Free Status

研究概览

简要总结

This is a randomized prospective study to compare stone free rates and operative efficiency of two laser systems used during retrograde intrarenal surgery for kidney stone disease:

  1. A superpulsed thulium fiber laser (thulium)
  2. A pulse modulated high power holmium laser (Holmium)

详细描述

This is a randomized prospective study. The purpose is to compare the stone free rate and operative efficiency of two leading contemporary laser systems used during retrograde intrarenal surgery for kidney stone disease. The researchers will compare the following two systems:

  1. A superpulsed thulium fiber laser (thulium)
  2. A pulse modulated high power holmium laser (Holmium)

The researchers will recruit 82 subjects undergoing single stage unilateral ureteroscopy for renal stones with a volume between >5mm to < 20 mm. Subjects will be randomized to undergo lithotripsy with either Ho:YAG or Thulium lasers.

All subjects will undergo surgical interventions that abide by broadly accepted guidelines and standards of care.

The primary outcome is stone free rate evaluated by postoperative CT scans done 6-12 weeks after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Number of Participants With Stone Free Status

时间窗: 6-12 weeks postoperative

Stone free status as determined by 6-12 week postoperative CT scan to assess laser efficacy

次要结局

  • Fragmentation Speed(Intraoperatively (Day 1))
  • Lasing Activity(Intraoperatively (Day 1))
  • Energy Utilization(Intraoperatively (Day 1))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mantu Gupta

Professor of Urology

Icahn School of Medicine at Mount Sinai

研究点 (2)

Loading locations...

相似试验